Linda Moore | General Counsel |
Pamela Marrone | Founder and Chief Executive Officer |
James Boyd | Chief Financial Officer |
Kevin Hammill | Chief Commercial Officer |
Sameer Joshi | H.C. Wainwright & Co. |
Benjamin Klieve | National Securities Corporation |
Robert Smith | Center for Performance Investing |
Good day, ladies and gentlemen, and welcome to the Marrone Bio Innovations Third Quarter 2018 Earnings Conference Call. Today’s conference is being recorded. At this time, I’d like to turn the conference over to Linda Moore, General Counsel. Please go ahead.
Good afternoon, everyone, and thank you for joining our call.